Exercise is essential for managing diabetes and reducing the risk of heart disease. Regular physical activity helps combat ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Researchers have found that engaging in moderate to vigorous physical activity during leisure time, regardless of ...

While heart disease is serious, it is important to understand how to control the risk factors and learn how to live a healthy ...

What is a menopause health assessment? And how will it improve the health care women receive during this stage in their lives ...

Federal funding for medical research has dropped by roughly $1 billion this year, raising alarm among universities, m ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...